Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Annals of Internal Medicine
|
January 7, 2020
Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes
Martin Mayer
Evidence-Based Medicine
|
October 22, 2015
Elucidating the use of enoxaparin in non-ST-elevation acute coronary syndromes (NSTE-ACS)
Martin Mayer
Annals of Internal Medicine
|
November 17, 2025
A Framework for Considering the Value of Race and Ethnicity in Estimating Disease Risk
Martin Mayer
Evidence-Based Medicine
|
January 1, 2016
Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the 'breakthrough'
Martin Mayer
Evidence-Based Medicine
|
April 7, 2016
Low-density lipoprotein cholesterol goals: still not in patients' best interest
Martin Mayer
BMJ Evidence-Based Medicine
|
March 1, 2019
Righteous indignation versus misplaced frustration: p values, CIs, effect sizes and the CASTLE-AF trial
Martin Mayer
Annals of Internal Medicine
|
April 15, 2024
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults
Martin Mayer
International Journal of Evidence-Based Healthcare
|
September 14, 2017
On P values and effect modification
Martin Mayer
BMJ Evidence-Based Medicine
|
May 2, 2019
Shared decision making for thromboembolic prophylaxis in non-valvular atrial fibrillation: promise and problems with the American College of Cardiology's AnticoagEvaluator (based on SPARCtool)
Martin Mayer
BMJ Evidence-Based Medicine
|
September 13, 2018
Research integrity and the law that never was
Martin Mayer
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Annals of Internal Medicine
|
January 7, 2020
Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes
Martin Mayer
Evidence-Based Medicine
|
October 22, 2015
Elucidating the use of enoxaparin in non-ST-elevation acute coronary syndromes (NSTE-ACS)
Martin Mayer
Annals of Internal Medicine
|
November 17, 2025
A Framework for Considering the Value of Race and Ethnicity in Estimating Disease Risk
Martin Mayer
Evidence-Based Medicine
|
January 1, 2016
Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the 'breakthrough'
Martin Mayer
Evidence-Based Medicine
|
April 7, 2016
Low-density lipoprotein cholesterol goals: still not in patients' best interest
Martin Mayer
BMJ Evidence-Based Medicine
|
March 1, 2019
Righteous indignation versus misplaced frustration: p values, CIs, effect sizes and the CASTLE-AF trial
Martin Mayer
Annals of Internal Medicine
|
April 15, 2024
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults
Martin Mayer
International Journal of Evidence-Based Healthcare
|
September 14, 2017
On P values and effect modification
Martin Mayer
BMJ Evidence-Based Medicine
|
May 2, 2019
Shared decision making for thromboembolic prophylaxis in non-valvular atrial fibrillation: promise and problems with the American College of Cardiology's AnticoagEvaluator (based on SPARCtool)
Martin Mayer
BMJ Evidence-Based Medicine
|
September 13, 2018
Research integrity and the law that never was
Martin Mayer
Page
of 9